(S)-N-(2-((S)-1-((S)-2-(4-(benzo[d]isothiazol-3-yl)piperazine-1-carbonyl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-ylamino)-2-oxoethyl)-2-(2-(3-(2-fluorophenyl)ureido)acetamido)-3-phenylpropanamide

ID: ALA3344245

Chembl Id: CHEMBL3344245

PubChem CID: 118717632

Max Phase: Preclinical

Molecular Formula: C41H48FN9O6S

Molecular Weight: 813.96

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  CC(C)[C@H](NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)Nc1ccccc1F)C(=O)N1CCC[C@H]1C(=O)N1CCN(c2nsc3ccccc23)CC1

Standard InChI:  InChI=1S/C41H48FN9O6S/c1-26(2)36(40(56)51-18-10-16-32(51)39(55)50-21-19-49(20-22-50)37-28-13-6-9-17-33(28)58-48-37)47-35(53)24-43-38(54)31(23-27-11-4-3-5-12-27)45-34(52)25-44-41(57)46-30-15-8-7-14-29(30)42/h3-9,11-15,17,26,31-32,36H,10,16,18-25H2,1-2H3,(H,43,54)(H,45,52)(H,47,53)(H2,44,46,57)/t31-,32-,36-/m0/s1

Standard InChI Key:  ZNKANCANAUAWKX-QOVAEWSBSA-N

Alternative Forms

1. Parent:

   

   ALA3344245

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 813.96

Molecular Weight (Monoisotopic): 813.3432

AlogP: 2.88

#Rotatable Bonds: 14

Polar Surface Area: 185.18

Molecular Species: NEUTRAL

HBA: 9

HBD: 5

#RO5 Violations: 1

HBA (Lipinski): 15

HBD (Lipinski): 5

#RO5 Violations (Lipinski): 2

CX Acidic pKa: 11.34

CX Basic pKa: 2.67

CX LogP: 2.86

CX LogD: 2.86

Aromatic Rings: 4

Heavy Atoms: 58

QED Weighted: 0.13

Np Likeness Score: -1.32

References

1. Sharma A, Suhas R, Banu SH, Chandrashekar S, Gowda DC..  (2014)  Implications of N-capped urea/thiourea and C-capped 3-(1-piperazinyl)-1,2-benzisothiazole with bridging Gly-Val/Phe-Gly-Val-Pro as therapeutic targets.,  87  [PMID:25305332] [10.1016/j.ejmech.2014.09.098]

Source

Source(1):

• Scientific Literature